NPHS1 and plasma cell myeloma: comparing different detection methods of anti-nephrin as well as unpublished data from other laboratories suggest that the use of commercially available recombinant human nephrin, which is expressed in non-human mouse myeloma cells and most likely differs from human expressed nephrin in regard to post-translational modifications, causes high false-positive results [10, 14].